BioLife Solutions (BLFS) Stock Analysis & Winston Score
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-o
Winston Score: 36/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Mixed (11/30)
- Growth: Mixed (8/20)
- Cash Flow: Weak (0/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $29.15
Market Cap: $1.4B
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Exchange: NASDAQ
